One atypical meningioma (16M), carrying an MSH2 truncating mutation, had loss of MSH2 and MSH6 immunostaining in all tumor cells (Figure 2), but none of the five microsatellites analyzed were unstable. This evidence concerns the gene MSH2 and neoplasm.